These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6919479)

  • 1. Controversies in the treatment of exocrine pancreatic insufficiency.
    DiMagno EP
    Dig Dis Sci; 1982 Jun; 27(6):481-4. PubMed ID: 6919479
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
    Gow R; Bradbear R; Francis P; Shepherd R
    Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
    Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
    N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic enzyme replacement: the effect of antacids or cimetidine.
    Graham DY
    Dig Dis Sci; 1982 Jun; 27(6):485-90. PubMed ID: 6282548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.
    Durie PR; Bell L; Linton W; Corey ML; Forstner GG
    Gut; 1980 Sep; 21(9):778-86. PubMed ID: 7429342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pancreatic Schilling test to determine efficiency of pancreatic enzyme delivery in pancreatic insufficiency.
    Brugge WR; Goldberg HJ; Burke CA; Depping BJ
    Dig Dis Sci; 1988 Oct; 33(10):1226-32. PubMed ID: 3168695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pH-sensitive enteric-coated pancreatic enzyme preparations: an evaluation of therapeutic efficacy in adult patients with pancreatic insufficiency.
    Dutta SK; Tilley DK
    J Clin Gastroenterol; 1983 Feb; 5(1):51-4. PubMed ID: 6551402
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of exocrine pancreatic insufficiency].
    Lankisch PG; Lembcke B
    Dtsch Med Wochenschr; 1984 May; 109(18):720-2. PubMed ID: 6562014
    [No Abstract]   [Full Text] [Related]  

  • 11. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J; Lerner S; Meyer JH
    Dig Dis Sci; 1988 Oct; 33(10):1245-9. PubMed ID: 3168697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exocrine pancreatic insufficiency. Comparison of substitution therapy with a non-acid resistant and an acid resistant enzyme preparation].
    Freise J; Horstkotte H
    Fortschr Med; 1986 Sep; 104(33):625-8. PubMed ID: 3639835
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J; Sólyom E
    Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of cimetidine as an adjunct to supplemental pancreatic enzymes in patients with cystic fibrosis.
    Hubbard VS; Dunn GD; Lester LA
    Am J Clin Nutr; 1980 Nov; 33(11):2281-6. PubMed ID: 7435406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK; Hubbard VS; Appler M
    Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation by the PABA test of the effects of cimetidine combined with pancreatic extracts in severe pancreatic insufficiency].
    Delchier JC; Soulé JC; Pariente EA; Bader JP
    Gastroenterol Clin Biol; 1983; 7(6-7):636-8. PubMed ID: 6603384
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G; Morrison JM; Redmond AO; Byers CA; McCracken KJ; Dodge JA; Guilford SA; Bowden MW
    Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of steatorrhea in chronic pancreatitis.
    Graham DY
    Hosp Pract (Off Ed); 1986 Jan; 21(1):125-9. PubMed ID: 3080447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.